Biography:
Dr. Engelking completed undergraduate studies in biochemistry at Texas A&M University (1996-2000), joint MD/PhD training (2000-2007) at UT Southwestern in Dallas, where he studied cholesterol metabolism under Nobel Laureates Goldstein and Brown. He then completed clinical training at Massachusetts General Hospital (2007-2010), an affiliate of Harvard Medical School, and then returned to UT Southwestern for clinical and research fellowship in gastroenterology (2010-2014). He is a teaching gastroenterologist and serves as the director of the Hereditary GI Cancer Clinic. His laboratory focuses on lipid metabolism in the GI tract and in GI cancers.
SREBPs in the control of intestinal homeostasis and tumorigenesis